Lehrstuhl für Innere Medizin I (Medizin 1)

A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and Consultation Center. (2024) Cuba L, Dürr P, Geßner K, Häcker B, Fietkau R, Siebler J, Pavel ME, et al. Journal article Alzheimer’s disease-related presenilins are key to intestinal epithelial cell function and gut immune homoeostasis (2024) Erkert L, Gamez-Belmonte R, Kabisch M, Schödel L, Patankar J, Gonzalez Acera M, Mahapatro M, et al. Journal article Cellular immunotherapies and immune cell depleting therapies in inflammatory bowel diseases: the next magic bullet? (2024) Neurath M, Sands BE, Rieder F Journal article Tofacitinib Affects M1-like and M2-like Polarization and Tissue Factor Expression in Macrophages of Healthy Donors and IBD Patients. (2024) Lethen I, Lechner-Grimm K, Gabel M, Knauß A, Atreya R, Neurath M, Weigmann B Journal article Transcriptomic analysis of intestine following administration of a transglutaminase 2 inhibitor to prevent gluten-induced intestinal damage in celiac disease (2024) Dotsenko V, Tewes B, Hils M, Pasternack R, Isola J, Taavela J, Popp A, et al. Journal article Exosomal ROR1 in peritoneal fluid identifies peritoneal disseminated PDAC and is associated with poor survival (2024) Mittelstädt A, Anthuber A, David P, Podolska M, Benard A, Brunner M, Krautz C, et al. Journal article A computer-aided detection system in the everyday setting of diagnostic, screening and surveillance colonoscopy: an international, randomized trial (2024) Maas MHJ, Rath T, Spada C, Soons E, Forbes N, Kashin S, Cesaro P, et al. Journal article Upadacitinib Reduces Crohn's Disease Symptoms Within the First Week of Induction Therapy (2024) Colombel JF, Hisamatsu T, Atreya R, Bresso F, Thin L, Panaccione R, Parra RS, et al. Journal article Teachability of multispectral optoacoustic tomography (2024) Li Y, Gröhl J, Haney B, Caranovic M, Lorenz-Meyer E, Papatheodorou N, Kempf J, et al. Journal article Real-World Effectiveness of Vedolizumab vs Anti-TNF in Biologic-naïve Crohn's Disease Patients: A 2-year Propensity-score-adjusted Analysis from the VEDOIBD-Study. (2024) Bokemeyer B, Plachta-Danielzik S, Di Giuseppe R, Efken P, Mohl W, Hoffstadt M, Krause T, et al. Journal article